PL346861A1 - Bifunctional antibodies and their use in targeting anti-tumour agents - Google Patents
Bifunctional antibodies and their use in targeting anti-tumour agentsInfo
- Publication number
- PL346861A1 PL346861A1 PL99346861A PL34686199A PL346861A1 PL 346861 A1 PL346861 A1 PL 346861A1 PL 99346861 A PL99346861 A PL 99346861A PL 34686199 A PL34686199 A PL 34686199A PL 346861 A1 PL346861 A1 PL 346861A1
- Authority
- PL
- Poland
- Prior art keywords
- bifunctional antibodies
- tumour agents
- targeting anti
- targeting
- tumour
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9819411.1A GB9819411D0 (en) | 1998-09-04 | 1998-09-04 | Antibodies |
PCT/GB1999/002938 WO2000014119A2 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents |
Publications (1)
Publication Number | Publication Date |
---|---|
PL346861A1 true PL346861A1 (en) | 2002-03-11 |
Family
ID=10838416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL99346861A PL346861A1 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1107995A2 (en) |
JP (1) | JP2002524470A (en) |
KR (1) | KR20010072988A (en) |
CN (1) | CN1315967A (en) |
AU (1) | AU5641299A (en) |
BG (1) | BG105293A (en) |
BR (1) | BR9913429A (en) |
CA (1) | CA2341753A1 (en) |
EA (1) | EA200100311A1 (en) |
GB (1) | GB9819411D0 (en) |
HR (1) | HRP20010154A2 (en) |
HU (1) | HUP0104091A2 (en) |
ID (1) | ID28873A (en) |
IL (1) | IL141524A0 (en) |
MX (1) | MXPA01002349A (en) |
NO (1) | NO20011102L (en) |
PL (1) | PL346861A1 (en) |
TR (2) | TR200103405T2 (en) |
WO (1) | WO2000014119A2 (en) |
ZA (1) | ZA200101574B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117442717A (en) | 2018-06-01 | 2024-01-26 | 大有华夏生物医药集团有限公司 | Compositions for treating diseases or conditions and uses thereof |
EP3826673A4 (en) * | 2018-07-26 | 2022-03-09 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Compositions and methods for imaging |
CN110811820B (en) * | 2019-12-11 | 2022-07-12 | 江西华晨医疗设备有限公司 | Straight rod type flushing and suction electrocoagulation cutter |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
IL89491A0 (en) * | 1988-11-17 | 1989-09-10 | Hybritech Inc | Bifunctional chimeric antibodies |
US5217713A (en) * | 1988-12-27 | 1993-06-08 | Takeda Chemical Industries, Ltd. | Cytotoxic bispecific monoclonal antibody, its production and use |
CA2069439A1 (en) * | 1989-12-15 | 1991-06-16 | Susumu Iwasa | Monoclonal antibodies, their production and use |
JPH05184383A (en) * | 1990-06-19 | 1993-07-27 | Dainabotsuto Kk | Bispecific antibody |
US6451980B1 (en) * | 1997-02-26 | 2002-09-17 | Ban-An Khaw | Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
-
1998
- 1998-09-04 GB GBGB9819411.1A patent/GB9819411D0/en not_active Ceased
-
1999
- 1999-09-06 WO PCT/GB1999/002938 patent/WO2000014119A2/en not_active Application Discontinuation
- 1999-09-06 BR BR9913429-2A patent/BR9913429A/en not_active IP Right Cessation
- 1999-09-06 ID IDW20010752A patent/ID28873A/en unknown
- 1999-09-06 EP EP99943138A patent/EP1107995A2/en not_active Withdrawn
- 1999-09-06 TR TR2001/03405T patent/TR200103405T2/en unknown
- 1999-09-06 HU HU0104091A patent/HUP0104091A2/en unknown
- 1999-09-06 MX MXPA01002349A patent/MXPA01002349A/en not_active Application Discontinuation
- 1999-09-06 EA EA200100311A patent/EA200100311A1/en unknown
- 1999-09-06 IL IL14152499A patent/IL141524A0/en unknown
- 1999-09-06 JP JP2000568876A patent/JP2002524470A/en active Pending
- 1999-09-06 AU AU56412/99A patent/AU5641299A/en not_active Abandoned
- 1999-09-06 PL PL99346861A patent/PL346861A1/en not_active Application Discontinuation
- 1999-09-06 CA CA002341753A patent/CA2341753A1/en not_active Abandoned
- 1999-09-06 KR KR1020017002437A patent/KR20010072988A/en not_active Application Discontinuation
- 1999-09-06 TR TR2001/00651T patent/TR200100651T2/en unknown
- 1999-09-06 CN CN99810368A patent/CN1315967A/en active Pending
-
2001
- 2001-02-26 ZA ZA200101574A patent/ZA200101574B/en unknown
- 2001-02-26 BG BG105293A patent/BG105293A/en unknown
- 2001-03-02 NO NO20011102A patent/NO20011102L/en unknown
- 2001-03-02 HR HR20010154A patent/HRP20010154A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0104091A2 (en) | 2002-03-28 |
HRP20010154A2 (en) | 2002-02-28 |
NO20011102L (en) | 2001-03-05 |
IL141524A0 (en) | 2002-03-10 |
AU5641299A (en) | 2000-03-27 |
BR9913429A (en) | 2001-09-25 |
BG105293A (en) | 2001-12-29 |
JP2002524470A (en) | 2002-08-06 |
WO2000014119A3 (en) | 2000-11-30 |
CN1315967A (en) | 2001-10-03 |
GB9819411D0 (en) | 1998-10-28 |
WO2000014119A2 (en) | 2000-03-16 |
TR200100651T2 (en) | 2001-07-23 |
ID28873A (en) | 2001-07-12 |
EP1107995A2 (en) | 2001-06-20 |
NO20011102D0 (en) | 2001-03-02 |
KR20010072988A (en) | 2001-07-31 |
EA200100311A1 (en) | 2001-08-27 |
MXPA01002349A (en) | 2003-10-15 |
TR200103405T2 (en) | 2002-06-21 |
CA2341753A1 (en) | 2000-03-16 |
ZA200101574B (en) | 2002-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69834346D1 (en) | Proteinexpression in baculovirus-vektor expressionsystemen | |
IL183948A (en) | Peg-urate oxidase conjugates and use thereof | |
EP0926955A4 (en) | Conjugates useful in the treatment of prostate cancer | |
GB9720108D0 (en) | Improvements in Magnotherapy | |
HUP0000651A3 (en) | Conjugates useful in the treatment of prostate cancer | |
IL136167A0 (en) | Conjugates useful in the treatment of prostate cancer | |
GB9708240D0 (en) | Improvements in or relating to contrast agents | |
GB9425600D0 (en) | Targeting complexes and use thereof | |
GB9725946D0 (en) | Lipid compositions and their use | |
GB9717588D0 (en) | Improvements in or relating to contrast agents | |
GB9717589D0 (en) | Improvements in or relating to contrast agents | |
PL346861A1 (en) | Bifunctional antibodies and their use in targeting anti-tumour agents | |
GB9701237D0 (en) | Improvements in or relating to contrast agents | |
ZA9810974B (en) | Conjugates useful in the treatment of prostate cancer | |
GB2316359B (en) | Combined greeting and cheque | |
GB9805630D0 (en) | Improvements in creamic materials | |
EP1150685A4 (en) | Phosphocholine surfactants and their use | |
GB9702652D0 (en) | Conjugates and their preparation | |
GB2321428B (en) | Improvements in marketing | |
GB9816014D0 (en) | Piperidinecarboxamides and their use | |
GB9718160D0 (en) | Conjugates useful in the treatment of prostate cancer | |
GB9715323D0 (en) | Piperidinecarboxamides and their use | |
GB9813825D0 (en) | Improvements in anti-hiv-1 and anticancer agents | |
GB9706758D0 (en) | Compositions and their use | |
GB9624170D0 (en) | Conjugates useful in the treatment of prostate cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |